MX382999B - Polvos pulmonares de ultra baja densidad - Google Patents

Polvos pulmonares de ultra baja densidad

Info

Publication number
MX382999B
MX382999B MX2019001520A MX2019001520A MX382999B MX 382999 B MX382999 B MX 382999B MX 2019001520 A MX2019001520 A MX 2019001520A MX 2019001520 A MX2019001520 A MX 2019001520A MX 382999 B MX382999 B MX 382999B
Authority
MX
Mexico
Prior art keywords
low density
ultra low
density lung
lung dust
dust
Prior art date
Application number
MX2019001520A
Other languages
English (en)
Inventor
Michael M Lipp
Richard P Batycky
Original Assignee
Merz Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/679,245 external-priority patent/US8545878B1/en
Application filed by Merz Pharmaceuticals Llc filed Critical Merz Pharmaceuticals Llc
Publication of MX382999B publication Critical patent/MX382999B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04—Methods of, or means for, filling the material into the containers or receptacles
    • B65B1/16—Methods of, or means for, filling the material into the containers or receptacles by pneumatic means, e.g. by suction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/20—Reducing volume of filled material
    • B65B1/26—Reducing volume of filled material by pneumatic means, e.g. suction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/30—Devices or methods for controlling or determining the quantity or quality or the material fed or filled
    • B65B1/36—Devices or methods for controlling or determining the quantity or quality or the material fed or filled by volumetric devices or methods
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/02—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles
    • B65B63/028—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles by pneumatic means

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Quality & Reliability (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Basic Packing Technique (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Oil, Petroleum & Natural Gas (AREA)

Abstract

La invención proporciona composiciones farmacéuticas para el suministro pulmonar que comprende partículas que contienen un agente farmacéutico y que tiene un tamaño geométrico mayor de 5 µm y una densidad compactada de menos de alrededor 0.075 g/cm3. La invención también proporciona métodos para el suministro de composiciones farmacéuticas de la invención al tracto respiratorio de un paciente.
MX2019001520A 2012-11-09 2013-11-08 Polvos pulmonares de ultra baja densidad MX382999B (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261724781P 2012-11-09 2012-11-09
US13/679,245 US8545878B1 (en) 2012-11-09 2012-11-16 Capsules containing high doses of levodopa for pulmonary use
US13/945,160 US8685442B1 (en) 2012-11-09 2013-07-18 Capsules containing high doses of levodopa for pulmonary use
US201361884436P 2013-09-30 2013-09-30
US201361884315P 2013-09-30 2013-09-30
US201361884319P 2013-09-30 2013-09-30
PCT/US2013/069107 WO2014074797A1 (en) 2012-11-09 2013-11-06 Ultra low density pulmonary powders

Publications (1)

Publication Number Publication Date
MX382999B true MX382999B (es) 2025-03-13

Family

ID=50685169

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2019001520A MX382999B (es) 2012-11-09 2013-11-08 Polvos pulmonares de ultra baja densidad
MX2015005767A MX377602B (es) 2012-11-09 2013-11-08 Cápsulas con altas dosis de levodopa para uso pulmonar.
MX2015005768A MX371008B (es) 2012-11-09 2013-11-08 Polvos pulmonares de ultra baja densidad.
MX2020012506A MX2020012506A (es) 2012-11-09 2015-05-07 Capsulas con altas dosis de levodopa para uso pulmonar.

Family Applications After (3)

Application Number Title Priority Date Filing Date
MX2015005767A MX377602B (es) 2012-11-09 2013-11-08 Cápsulas con altas dosis de levodopa para uso pulmonar.
MX2015005768A MX371008B (es) 2012-11-09 2013-11-08 Polvos pulmonares de ultra baja densidad.
MX2020012506A MX2020012506A (es) 2012-11-09 2015-05-07 Capsulas con altas dosis de levodopa para uso pulmonar.

Country Status (19)

Country Link
US (3) US9539211B2 (es)
EP (5) EP2925611B1 (es)
JP (6) JP6836834B2 (es)
KR (7) KR20210152020A (es)
CN (4) CN110833539A (es)
AU (6) AU2013342247C1 (es)
BR (2) BR112015010601B1 (es)
CA (3) CA2890459C (es)
DK (1) DK2916821T3 (es)
ES (2) ES2880271T3 (es)
HK (1) HK1212884A1 (es)
MX (4) MX382999B (es)
NZ (4) NZ733459A (es)
PL (1) PL2916821T3 (es)
PT (1) PT2916821T (es)
RU (2) RU2670987C2 (es)
SG (5) SG11201503547TA (es)
WO (3) WO2014074797A1 (es)
ZA (2) ZA201504058B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884046A (zh) 2012-10-22 2015-09-02 丝维塔斯治疗公司 用于快速缓解帕金森病的左旋多巴制剂
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
CN108700448B (zh) * 2016-02-06 2020-08-04 德国翰辉包装机械有限责任公司 刺戳吸移管
ITUA20163077A1 (it) * 2016-05-02 2017-11-02 Mg 2 Srl Gruppo di alimentazione per il dosaggio di granuli, in particolare microgranuli, in capsule
GB2550961A (en) * 2016-06-03 2017-12-06 Res Center Pharmaceutical Engineering Gmbh Apparatus for dosing a solid material into at least one receptacle
CN106394953A (zh) * 2016-06-24 2017-02-15 湖南千山制药机械股份有限公司 真空灌装系统
WO2019060797A1 (en) 2017-09-22 2019-03-28 Teva Branded Pharmaceutical Products R&D, Inc. PROCESS FOR PRODUCING POWDERS FOR INHALING
WO2019067708A1 (en) 2017-09-27 2019-04-04 Teva Branded Pharmaceutical Products R&D, Inc. METHOD FOR DECREASING PARTICLE SIZE
EP3833964B1 (en) 2018-08-07 2023-07-26 Norton (Waterford) Limited Application of raman spectroscopy for the manufacture of inhalation powders
EP3608015B1 (de) * 2018-08-08 2021-10-06 Harro Höfliger Verpackungsmaschinen GmbH Pulverbereitstellungseinrichtung für einen pulverdosierer
CN108995838A (zh) * 2018-09-10 2018-12-14 江西克莱威纳米碳材料有限公司 一种粉体装罐系统
CN109178367B (zh) * 2018-10-15 2021-01-26 楚天科技股份有限公司 用于粉体分装的灌装头和灌装装置
CN110040519B (zh) * 2019-04-30 2024-12-24 裕东（中山）机械工程有限公司 一种定量气固两相流输送装置及定量输送系统
EP3756640A1 (en) 2019-06-26 2020-12-30 Fette Compacting GmbH System and method for continuous production of solid dosage forms
RU2716294C1 (ru) * 2019-10-04 2020-03-11 Владимир Александрович Трусов Двухванная отражательная печь для переплава алюминиевого лома
CN115461045B (zh) * 2020-04-22 2026-01-02 比利时胶囊公司 粉末保留率降低的hpmc胶囊
IT202000008962A1 (it) * 2020-04-24 2021-10-24 Romaco Srl Apparecchiatura per il riempimento di contenitori con un materiale in polvere
CN116546980A (zh) * 2020-12-11 2023-08-04 江苏恒瑞医药股份有限公司 用于肺部递送的药物组合物
EP4201390A1 (de) * 2021-12-21 2023-06-28 Harro Höfliger Verpackungsmaschinen GmbH Kapselfüllmaschine zur befüllung zweiteiliger kapseln und verfahren zur befüllung zweiteiliger kapseln
EP4220101A1 (de) * 2022-01-26 2023-08-02 Harro Höfliger Verpackungsmaschinen GmbH Fülleinrichtung und füllsystem zum volumetrischen dosieren von pulver

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540059A (en) * 1947-08-02 1951-01-30 American Cyanamid Co Method of and apparatus for measuring and filling powders volumetrically
US3656518A (en) * 1967-03-27 1972-04-18 Perry Ind Inc Method and apparatus for measuring and dispensing predetermined equal amounts of powdered material
US3847191A (en) * 1971-08-23 1974-11-12 T Aronson Means and methods for measuring and dispensing equal amounts of powdered material
IT1069354B (it) * 1976-03-05 1985-03-25 Zanasi Nigris Spa Perfezionamenti nei dosatori volume trici
IT1156553B (it) * 1982-03-03 1987-02-04 Mg 2 Spa Procedimento per prelevare una quantita' prefissata di polvere dall'interno di un recipiente rotante e per depositare tale quantita' all'interno di un fondello di un contenitore di forma qualsiasi e macchina ch attui tale procedimento
JPS59115201A (ja) * 1982-12-10 1984-07-03 武田薬品工業株式会社 粉粒体処理機における粉粒体のシール装置
JPS63289922A (ja) * 1987-05-22 1988-11-28 Toshiba Corp 減圧気相成長装置
IT1245757B (it) * 1991-01-15 1994-10-14 Mg 2 Spa Macchina per il dosaggio di prodotti farmaceutici in polvere.
US5111642A (en) * 1991-01-23 1992-05-12 Macofar S.P.A. Machine for the dosage of powders in capsules, in particular for the pharmaceutical industry
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
ATE247948T1 (de) * 1996-04-29 2003-09-15 Dura Pharma Inc Verfahren zum inhalieren trockener pulver
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) * 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
JP2001507701A (ja) * 1996-12-31 2001-06-12 インヘイル・セラピューティック・システムズ・インコーポレーテッド 親水性賦形剤を有する疎水性薬剤の溶液を噴霧乾燥するための方法及びその方法によって作製された組成物
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040028735A1 (en) 1997-11-14 2004-02-12 Unchalee Kositprapa Pharmaceutical formulation
JP2002511399A (ja) * 1998-04-09 2002-04-16 セラニーズ ベンチャーズ ゲー・エム・ベー・ハー 肺投与のための粒状賦形剤
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
IT1304779B1 (it) * 1998-12-03 2001-03-29 Ima Spa Dosatrice a disco ed a pestelli, a funzionamento intermittente,monogiostra, particolarmente adatta per il confezionamento di dosi
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
GB9926335D0 (en) * 1999-11-05 2000-01-12 Powderject Res Ltd Apparatus and method for dispensing small quantities of particles
GB2356386A (en) 1999-11-17 2001-05-23 Tagra Biotechnologies Ltd Microencapsulation
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0014082D0 (en) * 2000-06-10 2000-08-02 Glaxo Group Ltd Method and apparatus for transferring a defined quantity of powder
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
AU2002230993B2 (en) 2000-12-29 2006-02-02 Alkermes, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) * 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US7621300B2 (en) * 2001-04-20 2009-11-24 Glaxo Group Limited Metering method for particulate material
EP1397134A2 (en) 2001-05-25 2004-03-17 Boehringer Ingelheim Pharma GmbH & Co.KG Combination of a dopamine d2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways
US6531153B2 (en) 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
WO2003043585A2 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
AU2003230689B2 (en) 2002-03-20 2006-06-29 Alkermes, Inc. Inhalable sustained therapeutic formulations
DK1485154T3 (da) 2002-03-20 2008-08-04 Alkermes Inc Pulverinhalationsindretning
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
ES2389156T3 (es) 2002-03-20 2012-10-23 Civitas Therapeutics, Inc. Administración pulmonar de levodopa
EP1503744A1 (en) * 2002-05-13 2005-02-09 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US6941980B2 (en) * 2002-06-27 2005-09-13 Nektar Therapeutics Apparatus and method for filling a receptacle with powder
MXPA04012712A (es) * 2002-06-27 2005-03-23 Nektar Therapeutics Aparato y metodo para controlar el flujo de un polvo.
EP1531794B1 (en) 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
ITBO20020525A1 (it) * 2002-08-08 2004-02-09 Ima Spa Macchina opercolatrice.
SI1565258T1 (sl) * 2002-11-26 2012-04-30 Univ Gent Postopek in naprava za neprekinjeno mokro granulacijo materiala v prahu
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP1617820B1 (en) * 2003-04-14 2018-03-21 Vectura Limited Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
DE20309279U1 (de) * 2003-06-12 2004-10-21 Harro Höfliger Verpackungsmaschinen GmbH Filterkolbenvorrichtung zum Abfüllen von pulvrigem Schüttgut
US7134459B2 (en) * 2003-06-12 2006-11-14 Symyx Technologies, Inc. Methods and apparatus for mixing powdered samples
WO2004112702A2 (en) 2003-06-13 2004-12-29 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
CA2552641A1 (en) * 2003-12-31 2005-07-21 Cydex, Inc. Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
SE0401842D0 (sv) * 2004-07-12 2004-07-12 Dizlin Medical Design Ab Infusion and injection solution of levodopa
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
US20060216345A1 (en) 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
US20060222699A1 (en) 2005-03-29 2006-10-05 Jonathan Gilinski Flavored vegetarian cellulose capsule and methods for producing said capsule.
AR055106A1 (es) 2005-08-05 2007-08-08 Osmotica Pharmaceutical Argent Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa
CN101243130B (zh) * 2005-08-05 2011-12-07 3M创新有限公司 显示具有改善的流动性的组合物
DE102005039765A1 (de) * 2005-08-23 2007-03-01 Robert Bosch Gmbh Sensiervorrichtung
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
US20120128728A1 (en) * 2005-12-28 2012-05-24 Novartis Pharma Ag Compositions Comprising Amphotericin B
EP2174637B1 (en) * 2005-12-29 2013-02-13 MG2 S.r.l Machine for filling capsules with a product
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US20080063722A1 (en) 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20100168410A1 (en) 2006-10-27 2010-07-01 Pfizer Products Inc. Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
EP2063867A2 (en) 2006-12-22 2009-06-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
UY31235A1 (es) * 2007-07-21 2009-03-02 Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
WO2009026434A1 (en) 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
GB2454480A (en) 2007-11-07 2009-05-13 Vectura Group Plc Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
CA2727630A1 (en) 2008-06-13 2009-12-17 Glaxo Group Limited Pharmaceutical formulations
ES2929343T3 (es) * 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
WO2010035273A2 (en) 2008-09-29 2010-04-01 Intec Pharma Ltd. Novel gastroretentive delivery system
IT1390803B1 (it) * 2008-09-30 2011-10-19 Mg2 Srl Apparecchiatura per la dosatura di materiali pulverulenti o granulari in capsule o similari
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
CA2744655A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Novel powdered crystalline medicines for inhalation
ES2625260T5 (es) * 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares
CA2759109A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd A solid dosage form of ciprofloxacin having small particle size and improved powder handling characteristics
IT1394027B1 (it) * 2009-05-11 2012-05-25 Mg 2 Srl Macchina per il riempimento di capsule con prodotti farmaceutici
US8359815B2 (en) * 2009-05-11 2013-01-29 Mg 2—S.R.L. Machine for filling capsules with pharmaceutical products
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
RU2445119C2 (ru) * 2010-05-25 2012-03-20 Сергей Викторович Чепур Фармацевтическая композиция и способ ее ингаляционного введения
US20120164233A1 (en) 2010-07-30 2012-06-28 Ranbaxy Laboratories Limited Pulsatile release pharmaceutical formulation of dexlansoprazole
EP2611438B1 (en) * 2010-08-30 2020-04-01 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
TW201304822A (zh) 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
CN107982246A (zh) 2012-10-22 2018-05-04 丝维塔斯治疗有限公司 降低左旋多巴血浆浓度的患者间可变性的方法相关申请
CN104884046A (zh) 2012-10-22 2015-09-02 丝维塔斯治疗公司 用于快速缓解帕金森病的左旋多巴制剂
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US8545878B1 (en) 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use
JP2017513866A (ja) 2014-04-21 2017-06-01 サイヴィタス セラピューティックス，インコーポレイテッド パーキンソン病の運動症状変動の迅速な緩和

Also Published As

Publication number Publication date
RU2670987C2 (ru) 2018-10-29
KR20240134230A (ko) 2024-09-06
CN109106697B (zh) 2022-02-15
AU2013342247A1 (en) 2015-07-02
ZA201504060B (en) 2016-04-28
HK1213535A1 (en) 2016-07-08
CA2890454C (en) 2020-10-27
US10238607B2 (en) 2019-03-26
EP2925611A1 (en) 2015-10-07
RU2676093C2 (ru) 2018-12-26
KR20230116102A (ko) 2023-08-03
NZ733459A (en) 2019-09-27
JP2015536197A (ja) 2015-12-21
EP2916826A4 (en) 2016-07-27
KR102907997B1 (ko) 2026-01-05
SG10201707103SA (en) 2017-10-30
US20150342890A1 (en) 2015-12-03
AU2018222983A1 (en) 2018-09-20
CN104918607A (zh) 2015-09-16
AU2013342248A1 (en) 2015-07-02
MX377602B (es) 2025-03-10
AU2013342248B2 (en) 2018-05-31
BR112015010601B1 (pt) 2022-07-19
JP2018162258A (ja) 2018-10-18
MX2020012506A (es) 2021-02-15
WO2014074796A1 (en) 2014-05-15
WO2014074795A1 (en) 2014-05-15
SG10201706465XA (en) 2017-09-28
BR112015010603A2 (pt) 2017-08-15
MX2015005768A (es) 2015-11-25
MX371008B (es) 2020-01-13
SG10202109328QA (en) 2021-10-28
RU2015121092A (ru) 2017-01-10
KR102257164B1 (ko) 2021-05-26
JP6347786B2 (ja) 2018-06-27
BR112015010603B1 (pt) 2022-10-11
DK2916821T3 (da) 2021-01-18
JP6669808B2 (ja) 2020-03-18
AU2018222983B2 (en) 2020-02-27
AU2013342247B2 (en) 2017-09-21
EP3815679A1 (en) 2021-05-05
CA2890459A1 (en) 2014-05-15
JP2019213867A (ja) 2019-12-19
EP2916821A4 (en) 2016-08-03
ZA201504058B (en) 2016-11-30
EP2925611B1 (en) 2022-03-09
ES2880271T3 (es) 2021-11-24
CN105120843A (zh) 2015-12-02
CA2890454A1 (en) 2014-05-15
KR20150108816A (ko) 2015-09-30
AU2013342246A1 (en) 2015-07-02
EP2916826B1 (en) 2021-04-28
NZ708684A (en) 2019-09-27
PL2916821T3 (pl) 2021-07-05
SG11201503547TA (en) 2015-06-29
WO2014074797A8 (en) 2014-06-26
KR20210152020A (ko) 2021-12-14
AU2018204674A1 (en) 2018-07-12
KR20220054703A (ko) 2022-05-03
ES2844153T3 (es) 2021-07-21
CA2890451A1 (en) 2014-05-15
CA2890451C (en) 2022-07-19
JP6836834B2 (ja) 2021-03-03
US20150342885A1 (en) 2015-12-03
RU2015121091A (ru) 2017-01-10
KR20150110480A (ko) 2015-10-02
JP6721629B2 (ja) 2020-07-15
AU2013342246B2 (en) 2018-03-29
US9539211B2 (en) 2017-01-10
WO2014074797A1 (en) 2014-05-15
JP2015536988A (ja) 2015-12-24
EP3957301A1 (en) 2022-02-23
JP6348501B2 (ja) 2018-06-27
AU2013342247C1 (en) 2017-12-21
BR112015010601A8 (pt) 2018-01-16
CN110833539A (zh) 2020-02-25
KR102735396B1 (ko) 2024-11-27
KR102389785B1 (ko) 2022-04-22
EP2916821B1 (en) 2020-10-21
CN109106697A (zh) 2019-01-01
KR102337781B1 (ko) 2021-12-09
EP2925611A4 (en) 2016-09-07
HK1213186A1 (en) 2016-06-30
EP2916821A1 (en) 2015-09-16
CA2890459C (en) 2022-08-23
BR112015010601A2 (es) 2017-08-15
NZ747376A (en) 2020-02-28
KR20210062730A (ko) 2021-05-31
PT2916821T (pt) 2021-01-21
JP2015536989A (ja) 2015-12-24
JP2018150355A (ja) 2018-09-27
EP2916826A1 (en) 2015-09-16
HK1214957A1 (zh) 2016-08-12
US20180036253A1 (en) 2018-02-08
SG11201503543PA (en) 2015-06-29
AU2017279626B2 (en) 2019-09-12
HK1212884A1 (zh) 2016-06-24
US9642812B2 (en) 2017-05-09
AU2017279626A1 (en) 2018-01-18
HK1213187A1 (en) 2016-06-30
AU2018204674B2 (en) 2019-09-19
MX2015005767A (es) 2015-11-25
CN104918607B (zh) 2018-10-12
NZ708682A (en) 2017-11-24

Similar Documents

Publication Publication Date Title
MX382999B (es) Polvos pulmonares de ultra baja densidad
CY1120605T1 (el) Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης
IN2014DN08672A (es)
PH12013502270A1 (en) Compositions, methods & systems for respiratory delivery of two or more active agents
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
WO2014007772A3 (en) Inhalation compositions comprising glucose anhydrous
CL2014003211A1 (es) Composicion farmaceutica para inhalacion que comprende aclidinio, con lactosa, que proporciona una dosis de 322 ug de base libre y aprox 140 ug de bromuro de aclidinio; un metodo para tratar una afeccion respiratoria seleccionada de asma y epoc; uso de la composicion; y un dispositivo inhalador de polvo seco calibrado que la comprende
WO2014007781A3 (en) Inhalation compositions
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
WO2014007771A3 (en) Inhalation compositions comprising muscarinic receptor antagonist
EA201201389A1 (ru) Ингалятор, создающий турбулентность
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
MX373699B (es) Composicion farmaceutica que contiene budesonida y formoterol.
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
IN2014MN02133A (es)
EP2866792A4 (en) MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
WO2013166430A3 (en) Delivery of gaseous imaging contrast agent
MX2017004633A (es) Formulaciones que contienen tiotropio, aminoacidos y acidos, y metodos de estas.
NZ747378A (en) Ultra low density pulmonary powders
MX372705B (es) Composición farmacéutica que contiene budesonida y formoterol
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
TR201000684A2 (tr) Formoterol ve mometazon içeren farmasötik bileşimler